U.S. High Court Won’t Review Medical Device Off-Label Preemption Debate
In 2010, Patricia Caplinger underwent lumbar spine surgery to treat a degenerative disc condition. Her surgeon used the Infuse bone graft made by Medtronic Inc., but he implanted it via a posterior approach, for which the device was not approved.
Caplinger alleges that a Medtronic...
To view the full article, register now.